AI in Healthcare Track Day One


AI in Healthcare 2018 Day One

Opening keynotes – AI in healthcare


Opening remarks from Terrapinn


How will AI disrupt the healthcare industry?

Reserved for supporting partner
Please contact Derek Cavanagh or Alistair Wilmot if interested in sponsoring​
Philipp M Diesinger

Artificial Intelligence transforming pharma and healthcare

Reserved for supporting partner
Please contact Derek Cavanagh or Alistair Wilmot if interested in sponsoring
Philipp M Diesinger, Global Chief Data Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG

Reserved for supporting partner

Reserved for supporting partner
Please contact Derek Cavanagh or Alistair Wilmot if interested in sponsoring

10:50 Networking Break

round tables

AI round table discussion session

  • Table 1: Transforming health care delivery through artificial intelligence
  • William Paiva

    William Paiva, Executive Director, Center for Health Systems Innovation, Oklahoma State University

  • Table 2: Is AI safety akin to clinical safety? Current issues in healthcare governance
  • Sam Smith

    Sam Smith, Co-ordinator, MedConfidential

  • Table 3: Investing in healthcare: emerging and exponential technologies
  • Dmitry Kaminskiy

    Dmitry Kaminskiy, Founding Partner, Deep Knowledge Ventures

  • Table 4: Solutions on sharing data
  • Table 5: How will we regulate AI?
  • Table 6: Making the patient experience better with AI
  • 13:10 Networking lunch

    AI pharma and research - drug discovery and biomarkers

    Healthcare delivery - using AI in hospitals

    AI for pharma and research

    Integrative big data for drug discovery

    • Innovation in drug discovery is becoming increasingly challenging requiring comprehensive objective decision making
    • Cancer therapy is becoming increasingly complex with drug resistance and tumor heterogeneity and tumor evolution
    • We have developed integrative data and machine learning / AI approaches to address some key bottle necks in drug discovery and adaptive cancer therapy
    Using AI in hospitals

    Our partnership with Deepmind

    •     Current use of the Streams application
    •     Future development of the Streams application
    Using AI in hospitals

    Using AI to improve healthcare

    • The challenges in social care
    • How social care needs to change
    • Where AI fits into social care
    AI for pharma and research

    Using our technology to speed up drug discovery

    Reserved for supporting partner
    Please contact Derek Cavanagh or Alistair Wilmot if interested in sponsoring
    Using AI in hospitals

    Data analytics and AI for healthcare transformation

    • The healthcare crisis can only be addressed if healthcare model is transformed
    • Value-based healthcare is the new paradigm
    • Data are essential to implement the new model
    • Business intelligence and AI are two basic tools for value-based healthcare
    • A specific architecture for simulation, emulation and big data set generation will be presented
    AI for pharma and research

    Improving translation rates into the clinic through AI modeling of ADME/Tox

    • Discuss the current state-of-the-art modeling of ADME and toxicity
    • Examine some of the challenges/wins in applying AI modeling to ADME and toxicity
    • Explore case studies involving the use of these models to solve key challenges
    Using AI in hospitals

    Making diagnostics quantitative and intelligent using AI and machine learning

    Senior Representative, Viz.AI

    16:00 Networking Break

    AI for pharma and research

    Digitised biology and image analysis augment drug discovery

    • What does it mean to ‘see’ for a machine?
    • Impact of AI in image and video analysis for pharmaceutical industry
    • Our work in image analysis is currently focusing on a range of enabling topics in computer vision, image processing and pattern recognition with the goal of automation
    Using AI in hospitals

    Artificial Intelligence at the point of care

    • GOFAI: Good Old Fashioned AI has had many successes but has struggled to get professional adoption in healthcare
    • NEWFAI: New Fangled AI (or machine intelligence) promises a revolution but will face its own challenges
    • Human centred cognitive systems combine the strengths of both – time to invest?
    AI for pharma and research

    In silico prediction of novel therapeutic targets using gene – disease association data

    • Many target identification programmes that fail for efficacy reasons showing poor association between the drug target and the disease
    • We used a semi-supervised classification approach to explore whether gene – disease association data from the Open Targets platform is sufficient to predict therapeutic targets that are actively being pursued by pharmaceutical companies or are already on the marke.
    • We show that a neural network is able to predict therapeutic targets with over 70% accuracy demonstrating that disease association is predictive of the ability of a gene or a protein to work as a drug target
    Using AI in hospitals

    Using the cloud to power medical imaging

    Reserved for supporting partner
    Please contact Derek Cavanagh or Alistair Wilmot if interested in sponsoring
    AI for pharma and research

    Modeling pharmaceutical drug discovery datasets with machine learning

    • Application of neural networks to pharmaceutical datasets
    • Comparison of deep-learning based approaches to baseline methods
    • Discussion of relevant issues when applying machine learning in an industrial setting
    Using AI in hospitals

    The Wearable Clinic: Digital phenotyping using mobile health technologies

    • People with long-term conditions interact with the NHS through rigid pathways that poorly match the dynamic nature of their condition
    • Our vision is to enable new forms of collaborative care through dynamic personal care plans and mobile/wearable health technologies
    • Focusing on patients with servere mental illness, we present machine learning algorithms to assess social functioning and risk of psychotic relapse using community-acquired geolocation data

    18:20 Offsite drinks reception

    last published: 13/Dec/17 09:35 GMT



    The World Precision Medicine Congress is both a world-class conference, bringing together hundreds of pharma, biotech and academic leaders from around the globe, and a fantastic exhibition showcasing the newest technologies, developments and solutions. There is a registration fee to attend the congress, however the exhibition is absolutely free to attend 

    phone: +44 (0)207 092 1134